Cafepharma Today

November 20 2024 - Novo, Viking heat up MASH space with promising data at AASLD24
Novo, Viking heat up MASH space with promising data at AASLD24
Pfizer, under pressure to change, names oncology head as new R&D chief
What might a Trump administration mean for the Biosecure Act?
Sage wilts as Huntington's prospect flunks trial
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Eisai, Biogen eye 2025 approval for Leqembi autoinjector
Pharmaphorum
Friday, November 1, 2024 - 10:57am
tags:
Eisai, Biogen, Leqembi, Alzheimer's disease, FDA
UCB's tau drug flunks phase 2 Alzheimer's trial days after Roche's exit from $120M bet
Fierce Biotech
Friday, November 1, 2024 - 10:55am
tags:
UCB Pharma, clinical trials, Roche, Alzheimer's disease, bepranemab
Regeneron Reports Mixed Q3 Sales as Eylea Franchise Remains Under Pressure
BioSpace
Friday, November 1, 2024 - 10:54am
tags:
Regeneron, Eylea, earnings
Gardasil's China troubles haunt Merck in Q3, with execs warning of more obstacles ahead
Fierce Pharma
Thursday, October 31, 2024 - 10:50pm
tags:
Merck, earnings, Gardasil, Keytruda
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
CNBC
Thursday, October 31, 2024 - 10:48pm
tags:
Bristol Myers Squibb, earnings
Japan's Takeda raises full-year profit forecast amid restructuring
MSN/Reuters
Thursday, October 31, 2024 - 10:47pm
tags:
Takeda, earnings, restructuring
Boehringer Ingelheim drops obesity drug from Gubra partnership
Fierce Biotech
Thursday, October 31, 2024 - 10:45pm
tags:
Boehringer Ingelheim, Gubra, obesity
FDA’s new device chief faces challenges. Patient groups, industry are still optimistic.
BioPharma Dive
Thursday, October 31, 2024 - 10:43pm
tags:
FDA, devices, Medtech, patients, patient advocacy groups
Teva slapped with €463M fine over accusations it stymied Copaxone competition in Europe
Fierce Pharma
Thursday, October 31, 2024 - 10:42pm
tags:
Teva Pharmaceutical, competition, Europe, legal, Copaxone, MS
Amgen reaps Horizon buyout rewards in Q3 as it gears up for key biosim launches
Fierce Pharma
Thursday, October 31, 2024 - 9:43am
tags:
Amgen, earnings, Horizon
Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year
BioSpace
Thursday, October 31, 2024 - 9:42am
tags:
Amgen, obesity, MariTide
AbbVie taps T-cell engager tech from EvolveImmune to build next-gen cancer biologics
First Word Pharma
Thursday, October 31, 2024 - 9:39am
tags:
AbbVie, EvolveImmune, T-cell engager
GSK axes vaccine from $2.1B deal, switching to preclinical successor over 'increased competition'
Fierce Biotech
Thursday, October 31, 2024 - 9:37am
tags:
GSK, Affinivax, vaccines, pneumococcal disease
Global summit blends AI and biotech
Axios
Thursday, October 31, 2024 - 9:23am
tags:
artificial intelligence, biotech, Joe Biden
Lobbying groups pushing priorities in year-end package and in 2025
Fierce Healthcare
Thursday, October 31, 2024 - 9:22am
tags:
lobbying, payers, PBMs, Medicare Advantage
Baxter exits China IV fluids market amid tough local competition, US shortage
Fierce Pharma
Thursday, October 31, 2024 - 9:21am
tags:
Baxter International, Medtech, IVs, China
Medable partners with Google to launch clinical trial tracking software
Clinical Trials Arena
Thursday, October 31, 2024 - 9:20am
tags:
Medable, Google, clinical trials
Big Pharma earnings hang hope on the next generation of blockbusters
Pharma Voice
Thursday, October 31, 2024 - 9:19am
tags:
Pfizer, JNJ, Biogen, Novartis, earnings
Compass veers off course, delaying phase 3 psychedelic data and laying off 30% of staff
Fierce Biotech
Thursday, October 31, 2024 - 9:18am
tags:
COMPASS Pathways, clinical trials, psychedelic drugs, depression
Nasdaq debutante Septerna swells its IPO to $331m
Pharmaphorum
Thursday, October 31, 2024 - 9:16am
tags:
Septerna, IPOs

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Down There in the Nano-Flow
In the Pipeline
Large Chains’ Position in 2025’s Part D Pharmacy Networks: Supermarkets Take the Lead in a Shrinking PDP Market
Drug Channels
CNS Drug Development: Same As It Ever Was
In the Pipeline
From Integration to AI: The Data-Driven Future of Market Access
Drug Channels
On RFK Jr. And What We're In For
In the Pipeline
Natural-Ish Product Motifs
In the Pipeline
Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market
Drug Channels
Deuterium In Court
In the Pipeline
Drug Channels Outlook 2025 (NEW Live Video Webinar)
Drug Channels

Latest Jobs

Area Manager, Specialty Southeast
Fields, Oregon, 97710
CSL Behring
Neuroscience Account Manager - Milwaukee, WI
Milwaukee, Wisconsin, US
Lundbeck
BioPharmaceutical Account Manager - Houston South, TX
Houston, Texas, US
Lundbeck
Associate Director, Strategic Account Management -Pacific
San Francisco, California
AbbVie
Senior Director, US HIV Prevention Launch Hub Lead
Foster City, California
Gilead Sciences, Inc.
Therapy Development Manager Transcatheter Heart Valve
San Diego, California, 92189
Edwards Lifesciences
Neuroscience Account Manager (Psychiatry) - Missoula, MT
Missoula, Montana, 59812
Vanda Pharmaceuticals
Senior Account Manager IV Therapy - Northern CA / Nevada
Honolulu, Hawaii, 96814
Fresenius Kabi USA, LLC
Psychiatry Account Manager - Dayton West, OH
Oakwood, Ohio, 45873
Lundbeck
Neuroscience Account Manager (Psychiatry) - Detroit East, MI
Hamtramck, Michigan, 48212
Vanda Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information